Physician
Mark Everett Schulte, M.D.
According to 2025 Medicare claims, Mark Schulte, M.D. (NPI: 1093973471) practices rheumatology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is RHEUMATOLOGY CONSULTANTS OF WESTERN NEW YORK, P.C. (NPI: 1568532315; TIN: 202087498) and primary practice location at 14224-3444.
Schulte's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 209 traditional Medicare patients, billed 49,319 HCPCS/CPT codes, and received $887,145 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,912 prescription claims across 444 beneficiaries totaling $1,796,531 in drug costs, led by Enbrel Sureclick (Etanercept). 2018 DME data shows 11 claims. Open Payments data shows 30 records totaling $797. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $246,542 to $887,145. Similarly, Part D prescription costs have risen steadily, from $552,010 to $1,796,531. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.